Natural coniferous resin salve used to treat complicated surgical wounds: pilot clinical trial on healing and costs
- PMID: 22607295
- DOI: 10.1111/j.1365-4632.2011.05397.x
Natural coniferous resin salve used to treat complicated surgical wounds: pilot clinical trial on healing and costs
Abstract
Resin is a natural product of coniferous trees. Salves manufactured from spruce resin (Picea abies) have been used for centuries to treat wounds and skin infections. We report a pilot clinical trial designed to investigate healing rates, factors that contribute to delayed wound healing, cost-effectiveness, and incidence of allergic reactions when resin salve is used to treat complicated surgical wounds. The trial involved 23 patients in whom wound healing after surgery was delayed. These patients were assigned to resin salve treatment. The primary outcome measure was the number of days to complete wound healing. Secondary objectives included an assessment of factors contributing to delayed wound healing, an estimation of associated costs, and an investigation into the occurrence of allergic reactions related to resin salve therapy. The study achieved a healing rate of 100%. The mean ± SD healing time was 43 ± 24 days. The mean ± SD wound size (length × width × depth) was (29 ± 19) × (12 ± 7) × (4 ± 3) mm. Wound size, use of corticosteroids or other immunosuppressants, and immobilization were statistically significant (P < 0.05) contributors to delayed wound healing and impaired re-epithelialization. The total mean ± SD costs of the resin salve treatment were €45.0 ± 26.0 per patient during the entire treatment period and €1.2 ± 0.5 per treatment day. The rate of allergic reactions was 0%. The results of this pilot trial indicate that complicated surgical wounds may be treated successfully with resin salve. The treatment method is clinically effective and cost-effective, and the rate of allergic reactions is low.
© 2012 The International Society of Dermatology.
Similar articles
-
Beneficial effect of resin salve in treatment of severe pressure ulcers: a prospective, randomized and controlled multicentre trial.Br J Dermatol. 2008 May;158(5):1055-62. doi: 10.1111/j.1365-2133.2008.08461.x. Epub 2008 Feb 16. Br J Dermatol. 2008. PMID: 18284391 Clinical Trial.
-
Resin salve from the Norwegian spruce tree: a 'novel' method for the treatment of chronic wounds.J Wound Care. 2007 Feb;16(2):72-4. doi: 10.12968/jowc.2007.16.2.26999. J Wound Care. 2007. PMID: 17319621 Review. No abstract available.
-
Antibacterial effects of home-made resin salve from Norway spruce (Picea abies).APMIS. 2007 Apr;115(4):335-40. doi: 10.1111/j.1600-0463.2007.apm_548.x. APMIS. 2007. PMID: 17504300
-
Occlusive vs gauze dressings for local wound care in surgical patients: a randomized clinical trial.Arch Surg. 2008 Oct;143(10):950-5. doi: 10.1001/archsurg.143.10.950. Arch Surg. 2008. PMID: 18936373 Clinical Trial.
-
Refined Spruce Resin to Treat Chronic Wounds: Rebirth of an Old Folkloristic Therapy.Adv Wound Care (New Rochelle). 2016 May 1;5(5):198-207. doi: 10.1089/wound.2013.0492. Adv Wound Care (New Rochelle). 2016. PMID: 27134764 Free PMC article. Review.
Cited by
-
Phytochemical Characterization, Antioxidant, and Antimicrobial Activity of the Vegetative Buds from Romanian Spruce, Picea abies (L.) H. Karst.Molecules. 2024 May 3;29(9):2128. doi: 10.3390/molecules29092128. Molecules. 2024. PMID: 38731619 Free PMC article.
-
Spruce Balm-Based Semisolid Vehicles for Wound Healing: Effect of Excipients on Rheological Properties and Ex Vivo Skin Permeation.Pharmaceutics. 2023 Jun 8;15(6):1678. doi: 10.3390/pharmaceutics15061678. Pharmaceutics. 2023. PMID: 37376126 Free PMC article.
-
Evidence for Natural Products as Alternative Wound-Healing Therapies.Biomolecules. 2023 Feb 27;13(3):444. doi: 10.3390/biom13030444. Biomolecules. 2023. PMID: 36979379 Free PMC article. Review.
-
Influence of gamma irradiation on rosin properties and its antimicrobial activity.Sci Rep. 2023 Mar 18;13(1):4500. doi: 10.1038/s41598-023-31372-7. Sci Rep. 2023. PMID: 36934117 Free PMC article.
-
Clinical Prevalence, Antibiogram Profiling and Gompertz Growth Kinetics of Resistant Staphylococcus epidermidis Treated with Nanoparticles of Rosin Extracted from Pinus roxburghii.Antibiotics (Basel). 2022 Sep 19;11(9):1270. doi: 10.3390/antibiotics11091270. Antibiotics (Basel). 2022. PMID: 36140049 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical